Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIMPLE: Linezolid in Tuberculosis Meningitis
NCT03537495Phase 2Completed
- Sponsor
- Universitas Padjadjaran
- Start
- Jun 2021
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of linezolid in tuberculous meningitis (TBM), sponsored by Universitas Padjadjaran. Started Jun 2021; status: completed.
02
Drugs
linezolid
03
Conditions
tuberculous meningitis (TBM)
Beyond the preview
Go deeper on NCT03537495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537495.